Literature DB >> 16517420

Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor.

Annukka Paju1, Ulf-Håkan Stenman.   

Abstract

Trypsinogens and PSTI/TATI/SPINK1 are expressed, usually together, at high levels by the pancreas but also by many other normal and malignant tissues. The present review describes studies on the expression and putative functions of trypsinogens and PSTI/TATI/SPINK1 in the human body. The clinical aspects are discussed, including the correlations between expression of trypsinogens and PSTI/TATI/SPINK1 in tissues, serum, and urine of patients with pancreatitis or cancer and clinicopathological characteristics, i.e., the roles of trypsinogens and PSTI/TATI/SPINK1 in spontaneous and hereditary pancreatitis, tumor progression, and prognosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517420     DOI: 10.1080/10408360500523852

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  15 in total

1.  Clinical significance and expression of the PRSS3 and Wiskott-Aldrich syndrome protein family verprolin-homologous protein 1 for the early detection of epithelial ovarian cancer.

Authors:  Sima Azizmohammadi; Aghdas Safari; Mehri Seifoleslami; Rahman Ghaffarzadegan Rabati; Mohsen Mohammadi; Hamid Yahaghi; Susan Azizmohammadi
Journal:  Tumour Biol       Date:  2015-12-10

2.  Pancreatic secretory trypsin inhibitor: More than a trypsin inhibitor.

Authors:  Gai-Ping Wang; Cun-Shuan Xu
Journal:  World J Gastrointest Pathophysiol       Date:  2010-06-15

3.  Role of the tumor-associated trypsin inhibitor SPINK1 in cancer development.

Authors:  Ulf-Håkan Stenman
Journal:  Asian J Androl       Date:  2011-05-23       Impact factor: 3.285

4.  SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.

Authors:  Danyelle Winchester; Luisel Ricks-Santi; Tshela Mason; Muneer Abbas; Robert L Copeland; Desta Beyene; Emmanuel Y Jingwi; Georgia M Dunston; Yasmine M Kanaan
Journal:  Anticancer Res       Date:  2015-07       Impact factor: 2.480

5.  Do genetic variants in the SPINK1 gene affect the level of serum PSTI?

Authors:  Kiyoshi Kume; Atsushi Masamune; Hiroyuki Ariga; Shintaro Hayashi; Tetsuya Takikawa; Shin Miura; Noriaki Suzuki; Kazuhiro Kikuta; Shin Hamada; Morihisa Hirota; Atsushi Kanno; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2012-04-20       Impact factor: 7.527

6.  Carboxyl Ester Lipase May Not Mediate Lipotoxic Injury during Severe Acute Pancreatitis.

Authors:  Biswajit Khatua; Ram N Trivedi; Pawan Noel; Krutika Patel; Ravinder Singh; Cristiane de Oliveira; Shubham Trivedi; Vivek Mishra; Mark Lowe; Vijay P Singh
Journal:  Am J Pathol       Date:  2019-04-05       Impact factor: 4.307

7.  The role of SPINK1 in ETS rearrangement-negative prostate cancers.

Authors:  Scott A Tomlins; Daniel R Rhodes; Jianjun Yu; Sooryanarayana Varambally; Rohit Mehra; Sven Perner; Francesca Demichelis; Beth E Helgeson; Bharathi Laxman; David S Morris; Qi Cao; Xuhong Cao; Ove Andrén; Katja Fall; Laura Johnson; John T Wei; Rajal B Shah; Hikmat Al-Ahmadie; James A Eastham; Scott E Eggener; Samson W Fine; Kristina Hotakainen; Ulf-Håkan Stenman; Alex Tsodikov; William L Gerald; Hans Lilja; Victor E Reuter; Phillip W Kantoff; Peter T Scardino; Mark A Rubin; Anders S Bjartell; Arul M Chinnaiyan
Journal:  Cancer Cell       Date:  2008-06       Impact factor: 31.743

8.  Poly(A) RT-PCR measurement of diagnostic genes in pancreatic juice in pancreatic cancer.

Authors:  M Oliveira-Cunha; R J Byers; A K Siriwardena
Journal:  Br J Cancer       Date:  2011-01-18       Impact factor: 7.640

9.  Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer.

Authors:  Wendy Weijia Soon; Lance David Miller; Michael A Black; Cyril Dalmasso; Xiu Bin Chan; Brendan Pang; Chee Wee Ong; Manuel Salto-Tellez; Kartiki V Desai; Edison T Liu
Journal:  EMBO Mol Med       Date:  2011-06-08       Impact factor: 12.137

10.  Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma marker.

Authors:  Aileen Marshall; Margus Lukk; Claudia Kutter; Susan Davies; Graeme Alexander; Duncan T Odom
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.